Evidence map›Paper›PMID 40824336›Full record

ReviewTopics in current chemistry (Cham)2025

Recent Advances in Functionally Engineered Aptamers: Strategies and Applications.

Mengyue Liu, Shicai Xu, Yemin Guo, Xia Sun, Giovanna Marrazza

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mengyue LiuShandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, No. 566 Daxue Xilu, Dezhou, 253023, Shandong, China. mengyueliu@dzu.edu.cn.
Shicai XuShandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, No. 566 Daxue Xilu, Dezhou, 253023, Shandong, China.
Yemin GuoSchool of Agricultural Engineering and Food Science, Shandong University of Technology, No. 266 Xincun Xilu, Zibo, 255049, Shandong, China.
Xia SunSchool of Agricultural Engineering and Food Science, Shandong University of Technology, No. 266 Xincun Xilu, Zibo, 255049, Shandong, China.
Giovanna Marrazza"Ugo Schiff" Chemistry Department, University of Florence, Via Della Lastruccia 3, Sesto Fiorentino, 50019, Florence, Italy.

Funding

"Belt and Road" innovative talent exchange program for foreign experts DL2023023007LNational Natural Science Foundation of China 12274058Natural Science Foundation of Shandong Province ZR202210150017
6 · The paper itself

Abstract

Aptamers are oligonucleotide sequences selected in vitro that possess advantages such as small size, non-toxicity, and ease of modification. Aptamer-based biosensing is advancing rapidly owing to the high affinity and specificity of aptamers for target molecules. Nevertheless, their relatively flexible structure and susceptibility to degradation in biological environments pose challenges for practical applications. To address these issues, researchers are developing functionally engineered aptamers through structural modifications such as chimera formation and splitting. These advancements have significantly accelerated aptamer research across multiple fields. This review highlights recent progress in functionally engineered aptamers, summarizing their construction strategies and applications in sensing. It also analyzes the characteristics of different types of engineered aptamers and their multi-field applications. Finally, current bottlenecks and future prospects are critically discussed. This review provides a systematic overview of engineered aptamers from a functional perspective, offering valuable insights for ongoing research in this dynamic field.

Indexed as

Aptamers, NucleotideBiosensing TechniquesHumansSELEX Aptamer TechniqueAptamers, NucleotideApplicationApta-sensingFunctionally engineered aptamerPost-SELEX strategy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.